Latest Conference Articles

ATS.2021: At-risk Asthma Phenotypes Defined Using 4 Simple Metrics

ATS.2021: At-risk Asthma Phenotypes Defined Using 4 Simple Metrics

May 12th 2021

ATS

ATS.2021. Study authors categorized asthma patients using age at onset, T2 biomarkers, and IL-6 levels, creating 12 phenotypes for additional study.

ATS 2021: Severe COPD Exacerbations May be Associated with Increased Mortality Risk

ATS 2021: Severe COPD Exacerbations May be Associated with Increased Mortality Risk

May 12th 2021

ATS

ATS 2021: The risk of morbidity and death in patients with COPD increases among those with moderate exacerbation, and even more so for severe exacerbation, new research suggests.

ATS 2021: Researchers Project Burden of COPD Will be Worse in 2050, Especially in US

ATS 2021: Researchers Project Burden of COPD Will be Worse in 2050, Especially in US

May 11th 2021

ATS

In an abstract being presenting at the upcoming ATS 2021 International Conference, researchers estimate that by 2050 the US will lead the Americas in prevalence of COPD.

Black Women at Risk Early in Life for Future Cardiovascular Disease

Black Women at Risk Early in Life for Future Cardiovascular Disease

May 11th 2021

ACC

ACC.21: High rates of obesity, hypertension, and hyperlipidemia found in Black women in their 20s and 30s are of significant concern, says the author of a study to be presented at the ACC meeting.

ATS 2021: Triple Combination Therapy May Benefit “Wide Spectrum” of Patients with COPD

ATS 2021: Triple Combination Therapy May Benefit “Wide Spectrum” of Patients with COPD

May 11th 2021

ATS

American Thoracic Society 2021 International Conference: In a subset of patients from the ETHOS study, triple combination therapy was found beneficial for those with moderate COPD.

ACP: Lessons Learned during COVID-19 Pandemic

ACP: Lessons Learned during COVID-19 Pandemic

May 3rd 2021

ACP

CDC Director Rochelle Walensky, MD MPH, was a featured presenter at the recent ACP Internal Medicine Meeting 2021: Virtual Experience, where she spoke about lessons learned during COVID-19.

ACP: Clyde Yancy, MD, MSc Reviews Advances in Heart Failure Research and Treatment

ACP: Clyde Yancy, MD, MSc Reviews Advances in Heart Failure Research and Treatment

April 29th 2021

ACP

ACP: Clyde W Yancy, MD, gave a comprehensive update on a year's worth of pivotal science in treatment of heart failure. Here are the highlights.

Fauci: Widespread COVID-19 Vaccination, Precautions Key to Ending Pandemic

Fauci: Widespread COVID-19 Vaccination, Precautions Key to Ending Pandemic

April 29th 2021

ACP

The NIAID head said the timing of the end of the pandemic is really up to the public.

 Early Intervention in Weight Management: Treating Pre-Obesity

Early Intervention in Weight Management: Treating Pre-Obesity

April 29th 2021

Obesity Medicine Association

Research shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.

A Weight-centric Approach to Obesity with T2D: How Pharmacotherapy Works

A Weight-centric Approach to Obesity with T2D: How Pharmacotherapy Works

April 23rd 2021

Obesity Medicine Association

For frontline clinicians who care daily for patients with obesity and type 2 diabetes, a weight-centric approach to T2D, including antiobesity drugs, could help improve outcomes.